Cargando…
Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes
PURPOSE: The association between serum osteocalcin (OCN) levels and metabolic dysfunction-associated fatty liver disease (MAFLD) is still controversial. Moreover, few studies have explored their relationship in type 2 diabetes mellitus (T2DM) patients so far. The present study aimed to investigate t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719286/ https://www.ncbi.nlm.nih.gov/pubmed/36471670 http://dx.doi.org/10.2147/DMSO.S389794 |
_version_ | 1784843288974458880 |
---|---|
author | Wang, Yu-Jie Jin, Chun-Hua Ke, Jiang-Feng Wang, Jun-Wei Ma, Yi-Lin Lu, Jun-Xi Li, Mei-Fang Li, Lian-Xi |
author_facet | Wang, Yu-Jie Jin, Chun-Hua Ke, Jiang-Feng Wang, Jun-Wei Ma, Yi-Lin Lu, Jun-Xi Li, Mei-Fang Li, Lian-Xi |
author_sort | Wang, Yu-Jie |
collection | PubMed |
description | PURPOSE: The association between serum osteocalcin (OCN) levels and metabolic dysfunction-associated fatty liver disease (MAFLD) is still controversial. Moreover, few studies have explored their relationship in type 2 diabetes mellitus (T2DM) patients so far. The present study aimed to investigate the association of serum OCN levels with MAFLD in Chinese T2DM patients. METHODS: This cross-sectional, real-world study included 1889 Chinese T2DM inpatients. MAFLD was diagnosed by abdominal ultrasonography. Participants were divided into four groups according to serum OCN quartiles, among which the clinical characteristics were compared. The association of serum OCN levels with the presence of MAFLD was also analyzed in subjects. RESULTS: After controlling for sex, age, and diabetes duration, the prevalence of MAFLD significantly decreased across the serum OCN quartiles (55.3%, 52.0%, 48.6%, and 42.1% for the first, second, third, and fourth quartiles, respectively, P < 0.001 for trend). A fully adjusted multiple logistic regression analysis showed that serum OCN levels were independently and negatively associated with the presence of MAFLD in T2DM patients (odds ratio, 0.832; 95% confidence interval, 0.719–0.962; P = 0.013). Furthermore, there were significant decreases in HOMA-IR (P = 0.001 for trend) and C-reactive protein (P < 0.001 for trend) levels across the serum OCN quartiles after controlling for sex, age, and diabetes duration. CONCLUSION: Serum OCN levels were independently and negatively associated with the presence of MAFLD in Chinese T2DM patients, partially due to the improvement of insulin resistance and inflammation mediated by OCN. Serum OCN may be used as a biomarker to assess the risk of MAFLD in T2DM patients. |
format | Online Article Text |
id | pubmed-9719286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-97192862022-12-04 Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Wang, Yu-Jie Jin, Chun-Hua Ke, Jiang-Feng Wang, Jun-Wei Ma, Yi-Lin Lu, Jun-Xi Li, Mei-Fang Li, Lian-Xi Diabetes Metab Syndr Obes Original Research PURPOSE: The association between serum osteocalcin (OCN) levels and metabolic dysfunction-associated fatty liver disease (MAFLD) is still controversial. Moreover, few studies have explored their relationship in type 2 diabetes mellitus (T2DM) patients so far. The present study aimed to investigate the association of serum OCN levels with MAFLD in Chinese T2DM patients. METHODS: This cross-sectional, real-world study included 1889 Chinese T2DM inpatients. MAFLD was diagnosed by abdominal ultrasonography. Participants were divided into four groups according to serum OCN quartiles, among which the clinical characteristics were compared. The association of serum OCN levels with the presence of MAFLD was also analyzed in subjects. RESULTS: After controlling for sex, age, and diabetes duration, the prevalence of MAFLD significantly decreased across the serum OCN quartiles (55.3%, 52.0%, 48.6%, and 42.1% for the first, second, third, and fourth quartiles, respectively, P < 0.001 for trend). A fully adjusted multiple logistic regression analysis showed that serum OCN levels were independently and negatively associated with the presence of MAFLD in T2DM patients (odds ratio, 0.832; 95% confidence interval, 0.719–0.962; P = 0.013). Furthermore, there were significant decreases in HOMA-IR (P = 0.001 for trend) and C-reactive protein (P < 0.001 for trend) levels across the serum OCN quartiles after controlling for sex, age, and diabetes duration. CONCLUSION: Serum OCN levels were independently and negatively associated with the presence of MAFLD in Chinese T2DM patients, partially due to the improvement of insulin resistance and inflammation mediated by OCN. Serum OCN may be used as a biomarker to assess the risk of MAFLD in T2DM patients. Dove 2022-11-29 /pmc/articles/PMC9719286/ /pubmed/36471670 http://dx.doi.org/10.2147/DMSO.S389794 Text en © 2022 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wang, Yu-Jie Jin, Chun-Hua Ke, Jiang-Feng Wang, Jun-Wei Ma, Yi-Lin Lu, Jun-Xi Li, Mei-Fang Li, Lian-Xi Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes |
title | Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes |
title_full | Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes |
title_fullStr | Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes |
title_full_unstemmed | Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes |
title_short | Decreased Serum Osteocalcin is an Independent Risk Factor for Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes |
title_sort | decreased serum osteocalcin is an independent risk factor for metabolic dysfunction-associated fatty liver disease in type 2 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719286/ https://www.ncbi.nlm.nih.gov/pubmed/36471670 http://dx.doi.org/10.2147/DMSO.S389794 |
work_keys_str_mv | AT wangyujie decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes AT jinchunhua decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes AT kejiangfeng decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes AT wangjunwei decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes AT mayilin decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes AT lujunxi decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes AT limeifang decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes AT lilianxi decreasedserumosteocalcinisanindependentriskfactorformetabolicdysfunctionassociatedfattyliverdiseaseintype2diabetes |